Laser scleral microporation may solve biomechanical problem of presbyopia
CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Alex Lopez of Ace Vision Group discusses laser scleral microporation for presbyopia.
Lopez said the GenII device can potentially deliver improved near vision without compromising distance vision in patients with presbyopia. The company plans to do a study in the United States in 2026, potentially leading to commercial availability in the U.S. in 2027.
“Presbyopia is a biomechanical problem with refractive consequences,” he said. “We finally have a solution that can potentially restore biomechanical movement and help patients regain that near vision they want in a natural way.”
Explore More Articles
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) — Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and multiple scientific presentations at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual …
read moreDynamic Range of Focus of the Eye: Understanding Biomechanics and Kinematics: Part II
IN PART I OF THIS 3-PART series, we outlined the definition of ocular biomechanics and kinematics and described the mechanical laws under which they operate.1 In this article, we describe the specific elements and motions responsible for achieving Dynamic Range of Focus (DRoF), including the phases of vision from accommodation to disaccommodation (near to far) and disaccommodation …
read moreMicroporation may address aging in eye
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, AnnMarie Hipsley, DPT, PhD, discusses microporation therapeutics and its potential role in presbyopia treatment.
read more